Chester County News and Community Website
Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), headquartered in Exton, PA, is a clinical-stage biotechnology company focused on taking the next step in immuno-oncology therapies.
EXTON, PA — Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) recently reported its consolidated financial and operational results for the third quarter that ended September 30, 2022.
Idera Pharmaceuticals Reports Third Quarter 2022 Financial Results Read More EXTON, PA — Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) announced it recently completed the acquisition of Aceragen, Inc., a privately-held biotechnology company addressing rare, orphan pulmonary and rheumatic diseases for which …
Idera Pharmaceuticals Acquires Aceragen Read More EXTON, PA — Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) has reported its financial and operational results for the second quarter ended June 30, 2022.
Idera Pharmaceuticals Reports Second Quarter 2022 Financial Results Read More EXTON, PA — Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) this week shared positive interim results from Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands, regarding its investigator-sponsored trial, INTRIM 1, involving tilsotolimod, …
Idera Pharmaceuticals Shares Positive Results from Investigator-Sponsored Trial Read More EXTON, PA — Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) recently reported its financial and operational results for the first quarter ended March 31, 2022. “We continue to preserve cash while actively …
Idera Pharmaceuticals Reports First Quarter 2022 Financial Results Read More EXTON, PA — Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) recenlty reported its financial and operational results for the fourth quarter and year ended December 31, 2021.
Idera Pharmaceuticals Reports Fourth Quarter, Full Year 2021 Financial Results Read More EXTON, PA — Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) recently announced clinical updates regarding tilsotolimod, its synthetic Toll-like receptor 9 agonist.
Idera Pharmaceuticals Announces Tilsotolimod Updates Read More EXTON, PA — Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) this week reported its financial and operational results for the third quarter ended September 30, 2021.
Idera Pharmaceuticals Reports Third Quarter 2021 Financial Results, Provides Corporate Update Read More EXTON, PA — Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) recently reported its financial and operational results for the second quarter ended June 30, 2021.
Idera Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update Read More EXTON, PA — Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) recently reported its financial and operational results for the first quarter ended March 31, 2021.
Idera Pharmaceuticals Reports First Quarter 2021 Financial Results Read More